People · Operator
Named in public records as an officer, director or promoter · active 2011–2016 · Manufacturing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amyris, Inc. | — | Manufacturing | Series D+ | $1.6B | $77.1M | 2013 |
| Aerie Pharmaceuticals Inc | — | Biotechnology | Series D+ | $189.6M | $5.2B | 2011 |
GEOFFREY DUYK at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside GEOFFREY DUYK on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| JOHN DOERR | 1 | 14 |
| Brian Levy | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| DENNIS HENNER | 1 | 5 |
| Geoff Duyk | 1 | 5 |
| David Epstein | 1 | 5 |
| Gerald Cagle | 1 | 4 |
| James Mazzo | 1 | 4 |
| Neil Renninger | 1 | 4 |
| L. John Doerr | 1 | 4 |
| Patrick Pichette | 1 | 3 |
| Richard Rubino | 1 | 3 |
| Philippe Boisseau | 1 | 3 |
| DAVID GRYSKA | 1 | 3 |
| John Melo | 1 | 3 |
| GEOFFREY J DUYK | 1 | 2 |
| Carole Piwnica | 1 | 2 |
| DAVID MACK | 1 | 2 |
| DENNIS J HENNER | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.